Categories Earnings, Technology

Earnings Preview: Will Cisco wrap the year up in style?

Networking giant Cisco Systems (CSCO) is scheduled to report its fourth-quarter results after the bell on August 15. The company has been in the transition phase moving from a traditional network-based firm to a more stable and steady revenue flowing software-based provider.

Cisco has been reporting growth in sales for the past two quarters and analysts would expect the trend to continue in the fourth quarter. Analysts expect the networking provider to report earnings of $0.68 per share on sales of $12.77 billion. Last quarter, the company guided the fourth quarter earnings to be between $0.68 and $0.70 per share along with revenue growth of 4% to 6%.

In August, Cisco acquired Duo Security for $2.35 billion which would be beneficial to offer cloud-based security-related services to its clients. Analysts will be expecting the management to shed more light on the deal and how it is going to benefit in the immediate future in line with its business model shift.

For the third quarter, the company reported earnings of $0.66 per share on revenues of $12.5 billion, which topped analyst estimates on both the earnings and revenue front. Growth in revenues was aided by a double-digit increase in applications and security front. It’s worth noting that Cisco expects to garner at least 50% of revenues from the applications front by 2020. To achieve the 2020 goal, the company might look for bolt-on deals which would augur well to accomplish its milestone.

Related: Cisco Q3 results

Other key aspects to look for in the fourth quarter would be how product orders are shaping up from its enterprise customers. Besides, how the company fares on the traditional networking, routing and switching side as it faces stiff competition from the likes of Juniper Networks, HP Enterprise, and Huawei.

Cisco’s stock has risen about 15% in 2018 hitting a new 52-week high of $46.37 in July this year and has seen a 38% jump in the last 12 months.

Most Popular

Everything you need to know about Aktis Oncology’s upcoming IPO

IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the

Constellation Brands set to report Q3 2026 earnings. Here’s what to expect

Constellation Brands' (NYSE: STZ) performance across its portfolio has been under scrutiny recently as it navigates a challenging consumer environment marked by sluggish demand and competitive pressures. With the beer

Broadcom Stock: Valuation and margins under review amid AI tailwinds

Broadcom, Inc. (NASDAQ: AVGO) has emerged as a key AI infrastructure supplier, leveraging its expertise in custom AI accelerators, to expand beyond its legacy smartphone and storage chip businesses. However,

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top